Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Fernando de Andres-Trelles"'
Autor:
Dimitrios Athanasiou, Marion Haberkamp, Armando Magrelli, Jane Moseley, Fernando de Andres-Trelles, Andre Elferink, Mário M. Rosa
Publikováno v:
Neuromuscular Disorders. 29:514-516
Development of novel therapies for Duchenne muscular dystrophy (DMD) are driving the need for more efficient ways of detecting changes in disease- progression in DMD [1]. However, medicines' approval must be based on outcome measures that are accepta
Autor:
Ferrán Catalá-López, Diego Macías Saint-Gerons, César de la Fuente Honrubia, Fernando de Andres-Trelles
Publikováno v:
Medicina Clínica. 144:285-287
Autor:
César de la Fuente Honrubia, Ferrán Catalá-López, Fernando de Andres-Trelles, Diego Macías Saint-Gerons
Publikováno v:
Medicina Clínica (English Edition). 144:285-287
Autor:
Luca Pani, Christine C. Gispen-de Wied, Violeta Stoyanova, Yang Yu, Maria Isaac, Fernando de Andres-Trelles
Publikováno v:
European Neuropsychopharmacology. 22:804-811
The use of placebo in clinical trials, and, related to this, ethical and feasibility aspects, are often debated. However, regulatory authorities must ensure that only new drugs with a positive benefit/risk would be granted a marketing authorization.
Publikováno v:
Medicina Clínica. 133:427-432
Autor:
Antonio Salvador Sanz, Miguel Gil, Dolores Montero, Fernando de Andres-Trelles, Ferrán Catalá-López, Diana González Bermejo, César de la Fuente Honrubia, Diego Macías Saint-Gerons
Publikováno v:
Revista Española de Salud Pública v.89 n.2 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Redalyc
Revista Española de Salud Pública, Vol 89, Iss 2, Pp 159-171 (2015)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Redalyc
Revista Española de Salud Pública, Vol 89, Iss 2, Pp 159-171 (2015)
Fundamentos: Las nuevas recomendaciones respecto a la utilización de estatinas potentes y/o dosis altas (terapia intensiva) para el tratamiento de la enfermedad cardiovascular se han basado en la extrapolación de los resultados de los ensayos clín
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531b20e010519f7d6ceecc3af64eee6a
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1135-57272015000200005
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1135-57272015000200005
Autor:
Marion Haberkamp, Karl Broich, Sarah Durston, Antonio M. Persico, Luca Pani, Tony Charman, Michael V. Lombardo, Luke Mason, Sven Bölte, Declan G. Murphy, Christine Ecker, Simon Baron-Cohen, Koichi Okamoto, Emily J.H. Jones, Jordi Llinares-Garcia, Steve C.R. Williams, Lindsay Ham, Will Spooren, Spiros Vamvakas, David A. Collier, Emily Simonoff, Caroline Auriche-Benichou, Maria Isaac, Thomas Bourgeron, Valentina Mantua, Sabine Lenton, Andreas Meyer-Lindenberg, Robert Hemmings, Sitra Tauscher-Wisniewski, Mark H. Johnson, Eva Loth, Jan K. Buitelaar, Omar Khwaja, Andre Elferink, Gahan Pandina, Tobias Banaschewski, Laurence O'Dwyer, Fernando de Andres-Trelles
Publikováno v:
Nature Reviews. Drug Discovery, 15, 70-3
Nature Reviews. Drug Discovery, 15, 1, pp. 70-3
Nature Reviews Drug Discovery
Nature Reviews Drug Discovery, 2015, 15 (1), pp.70-3. ⟨10.1038/nrd.2015.7⟩
Nature Reviews Drug Discovery, Nature Publishing Group, 2015, 15 (1), pp.70-3. ⟨10.1038/nrd.2015.7⟩
Nature Reviews. Drug Discovery, 15, 1, pp. 70-3
Nature Reviews Drug Discovery
Nature Reviews Drug Discovery, 2015, 15 (1), pp.70-3. ⟨10.1038/nrd.2015.7⟩
Nature Reviews Drug Discovery, Nature Publishing Group, 2015, 15 (1), pp.70-3. ⟨10.1038/nrd.2015.7⟩
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8b52e50f2ae1731117d1c15e5e44af8
http://hdl.handle.net/2066/152326
http://hdl.handle.net/2066/152326
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 22(11)
Publikováno v:
General Pharmacology: The Vascular System. 25:903-908
1. In male mice, 80 inescapable footshocks (S-80) induce analgesic responses measured by the tail flick test that are blocked by naloxone and the kappa opioid antagonist, nor-binaltorphimine. We now study the nociceptive responses, induced after this
Publikováno v:
Physiology & Behavior. 53:1115-1119
The application of 80 footshocks (S-80) to mice induces a decrease in nociceptive responses as measured by the tail-flick test, which is opioid mediated as well as prevented by naloxone (10 mg/kg, SC). When the stress is prolonged up to 240 shocks (S